Phio Pharmaceuticals Corp.
Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA

Last updated:

Abstract:

The present disclosure relates to RNAi constructs with improved cellular uptake characteristics and methods of use of these compounds for silencing expression of long coding RNAs (IncRNAs).

Status:
Grant
Type:

Utility

Filling date:

19 Oct 2016

Issue date:

1 Jun 2021